Inhibition of the Growth of Patient-Derived Pancreatic Cancer Xenografts with the MEK Inhibitor Trametinib Is Augmented by Combined Treatment with the Epidermal Growth Factor Receptor/HER2 Inhibitor Lapatinib - Concepedia

Concepedia

Publication | Open Access

Inhibition of the Growth of Patient-Derived Pancreatic Cancer Xenografts with the MEK Inhibitor Trametinib Is Augmented by Combined Treatment with the Epidermal Growth Factor Receptor/HER2 Inhibitor Lapatinib

DOI Full Paper Access

86

Citations

31

References

2013

Year

Dustin M. Walters, James Lindberg, Sara J. Adair, Timothy E. Newhook, Catharine Cowan, Jayme B. Stokes, Cheryl A. Borgman, Edward B. Stelow, Bryce Lowrey, Maria E. Chopivsky,

References

	Year	Citations

Page 1